Galectin-1 may promote NRP-1 expression by activating IL-8 secretion, and then galectin-1 binds to NRP-1 that is highly expressed on the surface of CAFs or PSC, ultimately promoting PDAC tumor immune evasion. Here, NRP1 is linked to neoplasm.